Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01369745 · ClinicalTrials.gov registry record · Phase 2
A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis
A Phase 2 study, sponsored by Zalicus.
- Completed
- Registry status
- Phase 2
- Development phase
- 294
- Enrollment target
NCT01369745 is a Phase 2 study that has completed, run by Zalicus. The registered enrollment target is 294 participants.
The verdict
NCT01369745, a Phase 2 study, has completed, sponsored by Zalicus.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 294 participants
- Enrollment target
Study Summary
Thus study will test an experimental drug called Z-102 (combination of prednisolone and dipyridamole) to treat patients with moderate to severe rheumatoid arthritis.
Interventions
- DRUG Prednisone
- DRUG Prednisolone
- OTHER placebo
- DRUG dipyridamole
- DRUG Z102
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01369745
The ClinicalTrials.gov registry entry for NCT01369745 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 294 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zalicus, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Prednisone is the first listed.
NCT01369745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01369745 about?
NCT01369745 is a clinical study titled "A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis". Thus study will test an experimental drug called Z-102 (combination of prednisolone and dipyridamole) to treat patients with moderate to severe rheumatoid arthritis.
What is the current status of trial NCT01369745?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 294 participants. The study started on 2011-06. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01369745?
The interventions under investigation include: Prednisone (DRUG), Prednisolone (DRUG), placebo (OTHER), dipyridamole (DRUG), Z102 (DRUG).
Who is sponsoring clinical trial NCT01369745?
This trial is sponsored by Zalicus, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.